Multicenter retrospective study of transcatheter arterial embolisation for life-threatening haemorrhage in patients with uncorrected bleeding diathesis.
Bleeding
Coagulopathy
Endovasdcular treatment
Prolonged clotting time
Transcatheter arterial embolisation
Journal
CVIR endovascular
ISSN: 2520-8934
Titre abrégé: CVIR Endovasc
Pays: Switzerland
ID NLM: 101738484
Informations de publication
Date de publication:
10 Dec 2020
10 Dec 2020
Historique:
received:
15
09
2020
accepted:
29
11
2020
entrez:
10
12
2020
pubmed:
11
12
2020
medline:
11
12
2020
Statut:
epublish
Résumé
We retrospectively investigated outcomes of emergency TAE for the management of life-threatening haemorrhage in patients with uncorrected bleeding diathesis. This multicenter, retrospective, study, was designed to investigate the safety and efficacy of percutaneous TAE for the management of life-threatening haemorrhage in patients with uncorrected bleeding disorder at the time of embolization. All consecutive patients with uncorrected coagulation who underwent TAE for the treatment of haemorrhage, between January 1st and December 31th 2019 in three European centers were included. Inclusion criteria were thrombocytopenia (platelet count < 50,000/mL) and/or International Normalized Ratio (INR) ≥2.0, and/or activated partial thromboplastin time (aPTT) > 45 s, and/or a pre-existing underlying blood-clotting disorder such as factor VIII, Von Willebrand disease, hepatic cirrhosis with abnormal liver function tests. Primary outcome measures were technical success, rebleeding rate and clinical success. Secondary outcome measures included patients' 30-day survival rate, and procedure-related complications. In total, 134 patients underwent TAE for bleeding control. A subgroup of 17 patients with 18 procedures [11 female, mean age 70.5 ± 15 years] which represent 12.7% of the total number of patients, presented with pathological coagulation parameters at the time of TAE (haemophilia n = 3, thrombocytopenia n = 1, cirrhosis n = 5, anticoagulants n = 7, secondary to bleeding n = 1) and were analyzed. Technical success was 100%, as in all procedures the bleeding site was detected and successfully embolised. Clinical success was 100%, as none of the patients died of bleeding during hospitalization, nor was surgically treated for bleeding relapse. Only one rebleeding case was noted (5.9%) that was successfully treated with a second TAE. No procedure-related complications were noted. According to Kaplan-Meier analysis the estimated 30-day survival rate was 84.2%. TAE in selected patients with uncorrected bleeding diathesis should be considered as a suitable individualized management approach. Emergency TAE for life threatening haemorrhage in patients with coagulation cascade disorders should be used as an aid in realistic clinical decision making.
Sections du résumé
BACKGROUND
BACKGROUND
We retrospectively investigated outcomes of emergency TAE for the management of life-threatening haemorrhage in patients with uncorrected bleeding diathesis.
MATERIALS AND METHODS
METHODS
This multicenter, retrospective, study, was designed to investigate the safety and efficacy of percutaneous TAE for the management of life-threatening haemorrhage in patients with uncorrected bleeding disorder at the time of embolization. All consecutive patients with uncorrected coagulation who underwent TAE for the treatment of haemorrhage, between January 1st and December 31th 2019 in three European centers were included. Inclusion criteria were thrombocytopenia (platelet count < 50,000/mL) and/or International Normalized Ratio (INR) ≥2.0, and/or activated partial thromboplastin time (aPTT) > 45 s, and/or a pre-existing underlying blood-clotting disorder such as factor VIII, Von Willebrand disease, hepatic cirrhosis with abnormal liver function tests. Primary outcome measures were technical success, rebleeding rate and clinical success. Secondary outcome measures included patients' 30-day survival rate, and procedure-related complications.
RESULTS
RESULTS
In total, 134 patients underwent TAE for bleeding control. A subgroup of 17 patients with 18 procedures [11 female, mean age 70.5 ± 15 years] which represent 12.7% of the total number of patients, presented with pathological coagulation parameters at the time of TAE (haemophilia n = 3, thrombocytopenia n = 1, cirrhosis n = 5, anticoagulants n = 7, secondary to bleeding n = 1) and were analyzed. Technical success was 100%, as in all procedures the bleeding site was detected and successfully embolised. Clinical success was 100%, as none of the patients died of bleeding during hospitalization, nor was surgically treated for bleeding relapse. Only one rebleeding case was noted (5.9%) that was successfully treated with a second TAE. No procedure-related complications were noted. According to Kaplan-Meier analysis the estimated 30-day survival rate was 84.2%.
CONCLUSION
CONCLUSIONS
TAE in selected patients with uncorrected bleeding diathesis should be considered as a suitable individualized management approach. Emergency TAE for life threatening haemorrhage in patients with coagulation cascade disorders should be used as an aid in realistic clinical decision making.
Identifiants
pubmed: 33301058
doi: 10.1186/s42155-020-00186-3
pii: 10.1186/s42155-020-00186-3
pmc: PMC7728894
doi:
Types de publication
Journal Article
Langues
eng
Pagination
95Références
Aina R, Oliva VL, Therasse E et al (2001) Arterial embolotherapy for upper gastrointestinal hemorrhage: outcome assessment. J Vasc Interv Radiol 12:195–200
doi: 10.1016/S1051-0443(07)61825-9
Angle JF et al (2010) Quality improvement guidelines for percutaneous transcatheter embolization Society of Interventional Radiology Standards of Practice Committee. J Vasc Interv Radiol 21(10):1479–1486
doi: 10.1016/j.jvir.2010.06.014
Baron TH, Kamath PS, McBane RD (2013) Management of antithrombotic therapy in patients undergoing invasive procedures. N Engl J Med 368(22):2113–2124
doi: 10.1056/NEJMra1206531
Bauer JR et al (2004) Transcatheter arterial embolization in the trauma patient: a review. Semin Intervent Radiol 21(1):11–22
doi: 10.1055/s-2004-831401
Bookstein JJ, Goldstein HM (1973) Successful management of postbiopsy arteriovenous fistula with selective arterial embolization. Radiology. 109(3):535–536
doi: 10.1148/109.3.535
Chakraverty S, Flood K, Kessel D et al (2012) CIRSE guidelines: quality improvement guidelines for endovascular treatment of traumatic hemorrhage. Cardiovasc Intervent Radiol 35(3):472–482
doi: 10.1007/s00270-012-0339-7
Chun JY, Morgan R, Belli AM (2010) Radiological management of hemoptysis: a comprehensive review of diagnostic imaging and bronchial arterial embolization. Cardiovasc Intervent Radiol 33:240–250
doi: 10.1007/s00270-009-9788-z
Coccolini F, Stahel PF, Montori G et al (2017) Pelvic trauma: WSES classification and guidelines. World J Emerg Surg 12:5
doi: 10.1186/s13017-017-0117-6
Davidson JC, Rahim S, Hanks SE et al (2019) Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in patients undergoing percutaneous image-guided interventions-part I: review of anticoagulation agents and clinical considerations: endorsed by the Canadian Association for Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe. J Vasc Interv Radiol 30(8):1155–1167
doi: 10.1016/j.jvir.2019.04.016
Filippiadis DK, Binkert C, Pellerin O, Hoffmann RT, Krajina A (2017) Pereira PL cirse quality assurance document and standards for classification of complications: the cirse classification system. Cardiovasc Intervent Radiol 40(8):1141–1146
doi: 10.1007/s00270-017-1703-4
Hur S et al (2014) Safety and efficacy of transcatheter arterial embolization for lower gastrointestinal bleeding: a single-center experience with 112 patients. J Vasc Interv Radiol 25(1):10–19
doi: 10.1016/j.jvir.2013.09.012
Jaffe TA, Raiff D, Ho LM, Kim CY (2015) Management of anticoagulant and antiplatelet medications in adults undergoing percutaneous interventions. AJR Am J Roentgenol 205:421–428
doi: 10.2214/AJR.14.13342
Loffroy R, Rao P, Ota S et al (2010) Embolization of acute nonvariceal upper gastrointestinal hemorrhage resistant to endoscopic treatment: results and predictors of recurrent bleeding. Cardiovasc Intervent Radiol 33:1088–1100
doi: 10.1007/s00270-010-9829-7
Lopera JE (2010) Embolization in trauma: principles and techniques. Semin Intervent Radiol 27(1):14–28
doi: 10.1055/s-0030-1247885
Maegele M (2019) The diagnosis and treatment of acute traumatic bleeding and coagulopathy. Dtsch Arztebl Int 116(47):799–806
pubmed: 31847951
pmcid: 6937546
Melloul E, Denys A, Demartines N (2015) Management of severe blunt hepatic injury in the era of computed tomography and transarterial embolization: a systematic review and critical appraisal of the literature. J Trauma Acute Care Surg 79(3):468–474
doi: 10.1097/TA.0000000000000724
Né R, Chevallier O, Falvo N et al (2018) Embolization with ethylene vinyl alcohol copolymer (Onyx®) for peripheral hemostatic and non-hemostatic applications: a feasibility and safety study. Quant Imaging Med Surg 8(3):280–290
doi: 10.21037/qims.2018.04.03
Padia SA, Ingraham CR, Moriarty JM et al (2020) Society of Interventional Radiology Position Statement on Endovascular Intervention for Trauma. J Vasc Interv Radiol 31(3):363–369.e2
doi: 10.1016/j.jvir.2019.11.012
Patel IJ, Davidson JC, Nikolic B et al (2012) Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol 23(6):727–736
doi: 10.1016/j.jvir.2012.02.012
Pearl IJ et al (2019) Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in patients undergoing percutaneous image-guided interventions-part II: recommendations. J Vasc Interv Radiol 30:1168–1184
doi: 10.1016/j.jvir.2019.04.017
Ramaswamy RS et al (2014) Role of interventional radiology in the management of acute gastrointestinal bleeding. World J Radiol 6(4):82–92
doi: 10.4329/wjr.v6.i4.82
Revel-Mouroz P, Mokrane FZ, Collot S et al (2015) Hemostastic embolization in oncology. Diagn Interv Imaging 96(7–8):807–821
doi: 10.1016/j.diii.2015.06.008
Rösch J, Dotter CT, Brown MJ (1972) Selective arterial embolization. A new method for control of acute gastrointestinal bleeding. Radiology. 102(2):303–306
doi: 10.1148/102.2.303
Shi ZX, Yang J, Liang HW, Cai ZH, Bai B (2017) Emergency transcatheter arterial embolization for massive gastrointestinal arterial hemorrhage. Medicine (Baltimore) 96(52):e9437
doi: 10.1097/MD.0000000000009437
Spiliopoulos S, Festas G, Theodosis A et al (2019) Incidence and endovascular treatment of severe spontaneous non-cerebral bleeding: a single-institution experience. Eur Radiol 29(6):3296–3307
doi: 10.1007/s00330-018-5869-1
Spiliopoulos S, Inchingolo R, Lucatelli P et al (2018) Transcatheter arterial embolization for bleeding peptic ulcers: a multicenter study. Cardiovasc Intervent Radiol 41(9):1333–1339
doi: 10.1007/s00270-018-1966-4
Toyoda H, Nakano S, Kumada T et al (1996) Estimation of usefulness of N-butyl-2-cyanoacrylate-lipiodol mixture in transcatheter arterial embolization for urgent control of life-threatening massive bleeding from gastric or duodenal ulcer. J Gastroenterol Hepatol 11:252–258
doi: 10.1111/j.1440-1746.1996.tb00071.x
Valek V, Husty J (2013) Quality improvement guidelines for transcatheter embolization for acute gastrointestinal nonvariceal hemorrhage. Cardiovasc Intervent Radiol 36:608–612
doi: 10.1007/s00270-012-0462-5